about
Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage StudyClostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.Clostridium difficile infection in patients with neutropenia.Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.Clostridium difficile bacteremia, Taiwan.Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strainsBacteraemia secondary to pseudomembranous colitis.Gastrointestinal complications in children with acute myeloid leukemia.Bacteremia due to clostridium difficile: case report and review of the literature.Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile.Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer.Clostridium difficile bacteremia in an immunocompetent child.Ceftazidime in the treatment of serious Pseudomonas aeruginosa sepsis.Clostridium difficile infection precipitating hemolysis in glucose-6-phosphate dehydrogenase-deficient preterm twins causing severe neonatal jaundice.Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.
P2860
Q31108764-E010FF48-9269-4320-A31D-9278BEA8839CQ33561562-1D442DBC-0E7E-4613-8C87-EAA774758D2BQ34340965-A0D8AF6A-4745-48F3-87DE-80261391EF7BQ34372612-CED017CF-94A9-4156-9564-B099C309CF57Q34624447-D35FD80A-A02F-4C3F-84A2-F8DC04BB72F2Q35817536-85EFFA5F-4289-4503-8918-D7DC293329D8Q36472477-198F36B6-7272-46E8-B97C-6F87A3DF816EQ37196322-EBA5F2C1-0FB4-4D72-B324-B89C418AA77CQ37720759-3CF36782-C48D-40DC-BE96-DEF99F1639DAQ38157857-2DBEFA69-9E41-4843-9CD8-0C5067314385Q40206743-74141091-5ADD-4801-AE0F-C0B3AAC370F2Q42225665-F3D3BFF4-2599-49C7-8DB0-7C645AE8F49FQ42372946-BC260E47-1BBA-463C-9D0C-96614AA3C3E1Q42742095-81DF4C48-F9B6-4ACC-971C-5BC37B4619DCQ43489605-8D1C489C-F8DD-4F6D-9828-6186D7528A6DQ46828129-A1AD6378-448A-47FE-AA4C-0A0E751FC1A0Q55194285-A1BDDAE4-E940-4E7B-9B6B-39A1C35FC16F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clostridium difficile in haematological malignancy.
@en
Clostridium difficile in haematological malignancy.
@nl
type
label
Clostridium difficile in haematological malignancy.
@en
Clostridium difficile in haematological malignancy.
@nl
prefLabel
Clostridium difficile in haematological malignancy.
@en
Clostridium difficile in haematological malignancy.
@nl
P2093
P2860
P356
P1476
Clostridium difficile in haematological malignancy.
@en
P2093
P2860
P304
P356
10.1136/JCP.38.4.445
P407
P577
1985-04-01T00:00:00Z